about
A journey into a Mediterranean diet and type 2 diabetes: a systematic review with meta-analysesLifestyle modifications and erectile dysfunction: what can be expected?Insulin analogs and glycosylated hemoglobin target of less than 7% in type 2 diabetes: a systematic review of randomized trials.Relationship of baseline HbA1c, HbA1c change and HbA1c target of < 7% with insulin analogues in type 2 diabetes: a meta-analysis of randomised controlled trials.Long-term effect of mediterranean-style diet and calorie restriction on biomarkers of longevity and oxidative stress in overweight menEfficacy of insulin analogs in achieving the hemoglobin A1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials.Dipeptidyl peptidase-4 inhibitors in type 2 diabetes therapy--focus on alogliptin.Lifestyle approach for type 2 diabetes and metabolic syndrome.Diabetes and sexual dysfunction: current perspectives.Dietary factors, Mediterranean diet and erectile dysfunction.Prevention and control of type 2 diabetes by Mediterranean diet: a systematic review.Proportion of patients at HbA1c target <7% with eight classes of antidiabetic drugs in type 2 diabetes: systematic review of 218 randomized controlled trials with 78 945 patients.Colorectal cancer association with metabolic syndrome and its components: a systematic review with meta-analysis.Metabolic syndrome and postmenopausal breast cancer: systematic review and meta-analysis.Metabolic syndrome and endometrial cancer: a meta-analysis.Baseline glycemic parameters predict the hemoglobin A1c response to DPP-4 inhibitors : meta-regression analysis of 78 randomized controlled trials with 20,053 patients.New guidelines for metabolic targets in diabetes: clinician's opinion does matter.The development of new basal insulins: is there any clinical advantage with their use in type 2 diabetes?Which diet for prevention of type 2 diabetes? A meta-analysis of prospective studies.Glycaemic durability with dipeptidyl peptidase-4 inhibitors in type 2 diabetes: a systematic review and meta-analysis of long-term randomised controlled trials.Remission of type 2 diabetes: is bariatric surgery ready for prime time?Particulate matter pollutants and risk of type 2 diabetes: a time for concern?Intensification of insulin therapy with basal-bolus or premixed insulin regimens in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.Circulating CD34+ KDR+ endothelial progenitor cells correlate with erectile function and endothelial function in overweight men.Comment on: Wing et al. Effect of intensive lifestyle intervention on sexual dysfunction in women with type 2 diabetes: results from an ancillary Look AHEAD Study. Diabetes care 2013;36:2937-2944.Dietary glycemic index and glycemic load are associated with metabolic control in type 2 diabetes: The CAPRI experience.Linking prediabetes and cancer: a complex issue.Vitamin D deficiency in type 2 diabetic patients with hypogonadism.Effects of intensive lifestyle changes on erectile dysfunction in men.Effects of Mediterranean diet on sexual function in people with newly diagnosed type 2 diabetes: The MÈDITA trial.Comment on "The pros and cons of continuous glucose monitoring for patients with type 1 diabetes on multiple daily injections of insulin". Authors' reply.Comment on Edelman and Polonsky. Type 2 Diabetes in the Real World: The Elusive Nature of Glycemic Control. Diabetes Care 2017;40:1425-1432.Continuous glucose monitoring for patients with type 1 diabetes on multiple daily injections of insulin: pros and cons.Gender-differences in glycemic control and diabetes related factors in young adults with type 1 diabetes: results from the METRO study.Determinants of female sexual dysfunction in type 2 diabetes.Vitamin D and autoimmunity: what happens in autoimmune polyendocrine syndromes?From inflammation to sexual dysfunctions: a journey through diabetes, obesity, and metabolic syndrome.Circulating endothelial progenitor cells in type 1 diabetic patients with erectile dysfunction.Setting the hemoglobin A1c target in type 2 diabetes: a priori, a posteriori, or neither?Dipeptidyl peptidase-4 inhibitors and HbA1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials
P50
Q26799686-1A9BF27E-32E8-4834-A9D0-F4EE304CC2F4Q26866570-4D6BF451-4EEF-4154-A264-9CE10B491E91Q33848334-3D4FCB97-1A77-4723-AC88-1EC377ACE4D4Q33871459-851D0D22-FC34-4D0A-8F62-1D62F478ABA5Q34442801-794018E6-6681-416B-8CF7-25DA8F74AC07Q34507342-85F08EFA-9C28-4BBF-8366-B7F05032A829Q37195882-6B6DB51C-6880-48B6-91B4-C6A807380E4EQ37304363-9D6D1BD7-C33A-456C-83F2-833A69F5B81CQ37630425-C9075353-1833-4AB3-B985-746E6AA4558DQ37757147-134E9A80-5B39-442D-B509-B068917FD9C9Q37765005-6F196AC1-7986-4CA1-845D-9F1AFBFCE266Q37940567-6344B924-F512-482B-B75F-D64501F7DF7CQ38094977-FF7582F5-DA8A-4390-9D4C-F4E51A3E6551Q38097664-7A9F9EAD-387D-4707-B00D-29479FBA4848Q38103791-DEE87C99-C44B-44F1-A3BE-3FAC314170AFQ38163894-8A6D605F-0F9C-443C-89A8-79104709CD3CQ38188849-A52CDC28-D76D-4F0E-B6E9-A99F9E718C21Q38199712-B92CD50D-FE3B-4800-BA32-AD6511B9B61AQ38205408-31AC9162-252F-4AD7-AEF8-4BC79061F68EQ38219234-3EB43B08-DF6F-442E-82A8-385B4E32BE02Q38263768-0B83A943-01C5-4546-840F-DA7D1B0E0B44Q38507862-41AA0BDC-31BA-46A4-B5E1-4AE2CDACC518Q38568342-3E5CC3F4-9399-43D9-AAC9-FF516A4F44A3Q40007422-17010596-3DE6-4C85-8843-B72FC33918CEQ42922410-C0C552C6-0674-4A77-A542-EE1739BAA6BFQ43160838-8C55CDC5-99D1-4BF8-B978-A2E937E6C7BBQ44921293-B6E71368-FBBE-4DE3-8A65-0A1C2ECF196CQ45325095-2505A0AE-CF11-489F-B443-FF7319F2F266Q45372453-0F28597E-FBBB-4FD4-A25A-833CD713AB43Q48005006-93D3ED0C-A72E-43B9-9BF5-85E7C5035DE5Q48100914-9CCE1147-C35F-406A-99AD-2F9B95F90DC8Q48191203-E2D18B82-78F7-4E50-9E11-EEFD72372D87Q48367305-89F709A7-011D-4F3E-91C9-F1C335133158Q49891865-48820F29-1B2E-4587-9A5A-DC889B5D48D2Q51572713-7DA6BF8F-1D57-413A-8537-C64EF8989B61Q51667971-D28ACF3F-DF99-48EC-83D0-E15B702A2BFBQ51762247-016E6603-207B-4BDD-B122-B5CBFBCEE61CQ53081324-74E2CC4A-FABF-439B-9E88-FC9614181E0AQ58828945-751C3575-2406-4A99-B979-4C41E5B391C4Q58829034-8C7093F3-EE7B-4AFD-8636-376BA07B96B1
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Maria Ida Maiorino
@ast
Maria Ida Maiorino
@en
Maria Ida Maiorino
@es
Maria Ida Maiorino
@nl
Maria Ida Maiorino
@sl
type
label
Maria Ida Maiorino
@ast
Maria Ida Maiorino
@en
Maria Ida Maiorino
@es
Maria Ida Maiorino
@nl
Maria Ida Maiorino
@sl
prefLabel
Maria Ida Maiorino
@ast
Maria Ida Maiorino
@en
Maria Ida Maiorino
@es
Maria Ida Maiorino
@nl
Maria Ida Maiorino
@sl
P106
P1153
24344908200
P21
P31
P496
0000-0003-4659-7546